Argitalpenak (43) Ikertzaileren baten partaidetza izan duten argitalpenak

2006

  1. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production

    Journal of Virology, Vol. 80, Núm. 3, pp. 1376-1384

  2. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: In vivo and in vitro studies

    Gut, Vol. 55, Núm. 8, pp. 1188-1196

  3. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells

    Cancer Research, Vol. 66, Núm. 12, pp. 6129-6138

  4. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients

    European Respiratory Journal, Vol. 27, Núm. 5, pp. 902-907

  5. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning

    Journal of Experimental Medicine, Vol. 203, Núm. 13, pp. 2809-2815

  6. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins

    Journal of Viral Hepatitis, Vol. 13, Núm. 1, pp. 47-55

  7. Daptomicina. Perfil farmacológico

    Enfermedades Infecciosas y Microbiologia Clinica Monografias, Vol. 5, Núm. 3, pp. 34-40

  8. Diabetes in chronic liver disease: From old concepts to new evidence

    Diabetes/Metabolism Research and Reviews, Vol. 22, Núm. 4, pp. 274-283

  9. Differential regulation of the JNK/AP-1 pathway by S-adenosylmethionine and methylthioadenosine in primary rat hepatocytes versus HuH7 hepatoma cells

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 290, Núm. 6

  10. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing

    Journal of Virology, Vol. 80, Núm. 24, pp. 12236-12247

  11. El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones viráles crónicas

    Anales del sistema sanitario de Navarra, Vol. 29, Núm. 1, pp. 77-96

  12. Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccine

    Journal of Immunology, Vol. 176, Núm. 6, pp. 3753-3759

  13. Erratum: A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury (Cytokine (2003) 22 (12-20) DOI: 10.1016/S1043-4666(03)00101-7)

    Cytokine

  14. Estudio del grado de entendimiento y aceptación por nuestros pacientes de los consentimientos informados utilizados para endoscopia

    Revista Espanola de Enfermedades Digestivas, Vol. 98, Núm. 2, pp. 101-111

  15. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon

    Clinical Immunology, Vol. 118, Núm. 2-3, pp. 229-232

  16. Gender and chronic obstructive pulmonary disease in high-risk smokers

    Respiration, Vol. 73, Núm. 3, pp. 306-310

  17. Gender associated differences in determinants of quality of life in patients with COPD: A case series study

    Health and Quality of Life Outcomes, Vol. 4

  18. Gene therapy for viral hepatitis

    Expert Opinion on Biological Therapy, Vol. 6, Núm. 12, pp. 1263-1278

  19. Gene therapy of liver cancer

    World Journal of Gastroenterology

  20. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection

    Infection and Immunity, Vol. 74, Núm. 6, pp. 3396-3407